Multiple Myeloma | Oncology Today with Dr Neil Love: Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Edition

published 10 months ago by Dr Neil Love

Featuring an interview with Dr Nikhil Munshi about recently published and emerging research on the use of CAR T-cell therapy in multiple myeloma, including the following topics: Chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma (MM) — Nikhil C Munshi, MD (00:00) Case: A woman in her mid-60s with relapsed/refractory (R/R) IgG kappa MM treated with anti-BCMA CAR T-cell therapy (20:31) Case: A man in his early 60s with R/R MM with adverse cytogenetics (25:58) Case: A man in his late 70s with R/R IgG kappa MM who responds to re-treatment with CAR T-cell therapy (29:52) Future directions in anti-BCMA CAR T-cell therapies for MM; steps toward liberalizing eligibility criteria (33:08)   CME information and select publications

more episodes from Research To Practice | Oncology Videos